Sutureless conjunctiva-sparing M\u00fcllerectomy shorter than traditional M\u00fcller muscle-conjunctival resection for posterior ptosis repair <\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, July 5, 2023 (HealthDay News) — Sutureless conjunctiva-sparing M \u00bcllerectomy (CSM) surgery is a promising technique for mild-to-moderate blepharoptosis, with good long-term outcomes, according to a study published in the July issue of the American Journal of Ophthalmology<\/em>.<\/p>\n Ronald Mancini, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues describe a novel sutureless CSM surgery using medical records of 100 patients undergoing posterior ptosis repair surgery, with a minimum follow-up interval of six months. Outcome measures were assessed from margin reflex distance 1 (MRD1) and palpebral fissure height (PFH) at various time points after surgery.<\/p>\n The researchers found that at six months, the mean change in MRD1 and PFH was 2.85 \u00c2\u00b1 0.98 mm and 2.60 \u00c2\u00b1 1.38 mm, respectively. In 91 percent of cases, there was symmetry within 1 mm. On average, sutureless CSM took 4.42 minutes, compared with 8.45 minutes for traditional M \u00bcller muscle-conjunctival resection. No corneal abrasions or ocular complications were seen. There was a 2.3 percent reoperation rate per eye.<\/p>\n “Our study found that sutureless CSM is highly effective,” Mancini said in a statement. “Only 2.3 percent of the patients studied required a second surgery for either undercorrection or overcorrection, and none of the patients experienced a postoperative corneal abrasion or ocular complication.”<\/p>\n